CATAPLEXY
Clinical trials for CATAPLEXY explained in plain language.
Never miss a new study
Get alerted when new CATAPLEXY trials appear
Sign up with your email to follow new studies for CATAPLEXY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New once-nightly drug could simplify narcolepsy treatment
Symptom relief CompletedThis study tested a new once-nightly medication (FT218) for people with narcolepsy who experience excessive daytime sleepiness and sudden muscle weakness (cataplexy). It included 184 participants who either switched from a twice-nightly medication or were new to this type of trea…
Matched conditions: CATAPLEXY
Phase: PHASE3 • Sponsor: Avadel • Aim: Symptom relief
Last updated May 17, 2026 06:21 UTC
-
New drug shows promise for narcolepsy symptoms in long-term trial
Symptom relief CompletedThis study looked at the long-term safety and effectiveness of a drug called AXS-12 for people with narcolepsy who experience sudden muscle weakness (cataplexy) and extreme daytime sleepiness. Researchers followed 68 participants who had already completed an earlier study to see …
Matched conditions: CATAPLEXY
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:52 UTC